Human chorionic gonadotropin, follicle-stimulating hormone, and luteinizing hormone in patients with epithelial ovarian carcinoma
- 18 February 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 36 (2) , 219-225
- https://doi.org/10.1016/0090-8258(90)90178-n
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Plasma level of estradiol in patients with ovarian malignant tumorsGynecologic Oncology, 1988
- Testosterone, Shbg and Albumin in Patients with Ovarian CarcinomaActa Obstetricia et Gynecologica Scandinavica, 1986
- Plasma Progesterone and Androstenedione in Relation to Changes in Tumor Volume and Recurrence in Women with Ovarian CarcinomaGynecologic and Obstetric Investigation, 1986
- Progesterone as a possible tumor marker for “nonendocrine” ovarian malignant tumorsGynecologic Oncology, 1983
- Ectopic production of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) by ovarian carcinomaEuropean Journal of Cancer and Clinical Oncology, 1983
- Ectopic human chorionic gonadotropin: Gynecological tumors and nonmalignant conditionsGynecologic Oncology, 1980
- Multiple biochemical markers in patients with gynecologic malignanciesCancer, 1980
- Ectopic Production of Chorionic Gonadotropin and Its Subunits by Islet-Cell TumorsNew England Journal of Medicine, 1977
- Human Chorionic Gonadotropin-Like Substance in Nonendocrine Tissues of Normal SubjectsScience, 1977
- ENDOCRINE STUDIES IN POST‐MENOPAUSAL WOMEN WITH OVARIAN TUMOURSBJOG: An International Journal of Obstetrics and Gynaecology, 1971